There already exist non-opioid painkillers, such as ibuprofen ... but the biotech suggests its compound has the potential to be ‘best-in-class’. In addition to its lead asset, the biotech ...
Vertex Pharmaceuticals Inc. notched two FDA victories late Friday for its cystic fibrosis medicines, increasing the number of ...
The Series C – which was led by Novo Nordisk's parent company Novo Holdings – follows a $15 million second round for the ...
The market for non-opioid painkillers is booming in the wake of a devastating overdose crisis and an opioid industry far diminished from its heyday. Companies offering nonsurgical alternatives to ...
Some analysts had said the painkiller might be a multibillion-dollar business ... noting that health insurers and hospitals ...
The funds come from a $26 billion multistate court settlement reached with companies linked to distributing and manufacturing prescription painkillers linked to the opioid epidemic. The companies ...